Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
- PMID: 15475413
- DOI: 10.1124/dmd.104.001628
Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
Abstract
The aim of the present study was to assess the contribution of polymorphisms in the breast cancer resistance protein/ATP-binding cassette transporter G2 (BCRP/ABCG2) gene to the placental expression from a new perspective, allelic imbalance. Polymorphisms were screened by polymerase chain reaction (PCR)-single-strand conformation polymorphism analysis followed by sequencing with DNA extracted from 100 placentas. To examine whether polymorphisms of the BCRP gene correlate with the placental BCRP expression, we determined mRNA and protein levels by quantitative real-time PCR and Western blotting, respectively. In placentas, G34A (Val(12)Met) and C421A (Gln(141)Lys) were frequently observed (18-36%), but C376T, which creates a stop codon (Gln(126) stop codon), was found with an allelic frequency of 1%. The mean of the BCRP protein level was significantly lower (p < 0.05) in homozygotes for the A421 allele than in those for the C421 allele, and heterozygotes had an intermediate value. To evaluate whether the C421A polymorphism acts as a cis-element in BCRP transcription, allelic imbalance was determined using informative lymphoblasts and 56 samples of placental cDNA. In most of the placental samples we tested, the difference in expression levels between the two alleles was small, and only two samples indicated a monoallelic expression (i.e., preferential expression of one allele). These results suggest that 1) the predominant allelic expression pattern of BCRP in placental samples is biallelic, and 2) the mutation C421A is not a genetic variant acting in cis, but is considered to influence the translation efficiency.
Similar articles
-
Interindividual Regulation of the Breast Cancer Resistance Protein/ABCG2 Transporter in Term Human Placentas.Drug Metab Dispos. 2018 May;46(5):619-627. doi: 10.1124/dmd.117.079228. Epub 2018 Jan 31. Drug Metab Dispos. 2018. PMID: 29386232 Free PMC article.
-
Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.J Pharmacol Exp Ther. 2016 Apr;357(1):103-13. doi: 10.1124/jpet.115.230185. Epub 2016 Feb 5. J Pharmacol Exp Ther. 2016. PMID: 26850786 Free PMC article.
-
Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development.Cancer Lett. 2006 Mar 8;234(1):73-80. doi: 10.1016/j.canlet.2005.04.039. Epub 2005 Nov 21. Cancer Lett. 2006. PMID: 16303243 Review.
-
Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.Cancer Sci. 2005 Aug;96(8):457-65. doi: 10.1111/j.1349-7006.2005.00081.x. Cancer Sci. 2005. PMID: 16108826 Free PMC article. Review.
-
C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.Mol Cancer Ther. 2002 Jun;1(8):611-6. Mol Cancer Ther. 2002. PMID: 12479221
Cited by
-
Impacts of ABCG2 loss of function variant (p. Gln141Lys, c.421 C > A, rs2231142) on lipid levels and statin efficiency: a systematic review and meta-analysis.BMC Cardiovasc Disord. 2024 Apr 8;24(1):202. doi: 10.1186/s12872-024-03821-2. BMC Cardiovasc Disord. 2024. PMID: 38589776 Free PMC article.
-
ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity.Mol Genet Genomic Med. 2024 Mar;12(3):e2362. doi: 10.1002/mgg3.2362. Epub 2024 Mar 7. Mol Genet Genomic Med. 2024. PMID: 38451012 Free PMC article.
-
Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk.Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3891-3897. doi: 10.31557/APJCP.2023.24.11.3891. Asian Pac J Cancer Prev. 2023. PMID: 38019248 Free PMC article.
-
Placental BCRP transporter reduces cadmium accumulation and toxicity in immortalized human trophoblasts.Reprod Toxicol. 2023 Oct;121:108466. doi: 10.1016/j.reprotox.2023.108466. Epub 2023 Sep 1. Reprod Toxicol. 2023. PMID: 37660740
-
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic-pharmacokinetic and exposure-response analysis.Cancer Chemother Pharmacol. 2023 Oct;92(4):315-324. doi: 10.1007/s00280-023-04569-w. Epub 2023 Jul 27. Cancer Chemother Pharmacol. 2023. PMID: 37500985
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous